180 Life Sciences Reports Promising Results from Clinical Study on Solid CBD Formulation
180 Life Sciences Corp. Announces Positive Topline Results from Clinical Pharmacology Study on Novel Solid Cannabidiol Formulation PALO ALTO, Calif., July 30, 2024 180 Life Sciences Corp. (NASDAQ: ATNF) has recently dis...
Jul 30, 2024
• Major Pharmaceutical Preparations Industry
Clinical Study